Light Sciences Oncology raising up to $35 million in funding |
Connect with TechFlash on our Facebook page for all the latest technology news headlines and commentary, plus information and access to special events, photos from events, promotions and more.
Light Sciences Oncology, a Bellevue biotechnology company working on treatments for cancer, said today in a SEC filing that it has raised $35 million. The money comes in the form of a $23.3 credit facility, as well as $11.5 million in warrants.
Light Sciences filed to go public in April 2006, but rocky financial conditions forced the company to withdraw plans for the offering in February 2008.
In June of last year, the company raised $40 million in a series C financing deal.
The company's technology uses light-emitting diodes to activate drugs that can kill cancer tissue.
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.